Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free ESTA Stock Alerts

Establishment Labs (ESTA) Financials

Establishment Labs logo
$70.69 0.00 (0.00%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$70.02 -0.67 (-0.95%)
As of 05:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Establishment Labs

Annual Income Statements for Establishment Labs

This table shows Establishment Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -35 -21 -38 -38 -41 -75 -79 -85 -51
Consolidated Net Income / (Loss)		 -35 -21 -38 -38 -41 -75 -79 -85 -51
Net Income / (Loss) Continuing Operations		 -35 -21 -38 -38 -41 -75 -79 -85 -51
Total Pre-Tax Income 		-35 -21 -38 -38 -40 -73 -79 -85 -58
Total Operating Income		 -20 -24 -31 -28 -25 -40 -65 -50 -39
Total Gross Profit		 18 36 55 53 85 107 107 110 146
Total Revenue		 35 61 90 85 127 162 165 166 211
Operating Revenue		 35 61 90 85 127 162 165 166 211
Total Cost of Revenue		 17 25 35 32 41 55 58 57 65
Operating Cost of Revenue		 17 25 35 32 41 55 58 57 65
Total Operating Expenses		 38 60 86 80 111 146 172 160 185
Selling, General & Admin Expense		 31 47 71 67 92 126 146 140 165
Research & Development Expense		 6.86 13 15 14 18 20 26 20 20
Total Other Income / (Expense), net		 -15 2.98 -6.85 -10 -15 -33 -14 -35 -19
Interest Expense		 10 8.81 8.70 9.37 9.06 31 15 21 25
Interest & Investment Income		 0.02 0.02 0.00 0.02 0.02 0.09 1.02 1.48 0.42
Other Income / (Expense), net		 -4.41 12 1.85 -0.74 -5.53 -2.47 0.82 -15 5.82
Income Tax Expense		 0.11 0.22 0.64 0.10 1.43 2.39 -0.08 -0.03 -6.96
Basic Earnings per Share		 ($3.41) ($1.22) ($1.86) ($1.63) ($1.72) ($3.08) ($3.07) ($3.00) ($1.72)
Weighted Average Basic Shares Outstanding		 10.23M 17.35M 20.54M 23.32M 23.97M 24.46M 25.60M 28.16M 29.62M
Diluted Earnings per Share		 ($3.41) ($1.22) ($1.86) ($1.63) ($1.72) ($3.08) ($3.07) ($3.00) ($1.72)
Weighted Average Diluted Shares Outstanding		 10.23M 17.35M 20.54M 23.32M 23.97M 24.46M 25.60M 28.16M 29.62M
Weighted Average Basic & Diluted Shares Outstanding		 10.23M 17.35M 20.54M 23.32M 24.12M 24.42M 27.21M 28.85M 29.32M

Quarterly Income Statements for Establishment Labs

This table shows Establishment Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -29 -21 -16 -17 -17 -35 -21 -17 -11 -2.62 -13
Consolidated Net Income / (Loss)		 -29 -21 -16 -17 -17 -35 -21 -17 -11 -2.62 -13
Net Income / (Loss) Continuing Operations		 -29 -21 -16 -17 -17 -35 -21 -17 -11 -2.62 -13
Total Pre-Tax Income 		-29 -23 -16 -17 -16 -36 -20 -16 -11 -12 -13
Total Operating Income		 -21 -22 -8.83 -9.34 -13 -19 -17 -14 -4.03 -3.93 -6.51
Total Gross Profit		 26 21 24 29 26 30 28 35 38 46 42
Total Revenue		 39 32 37 44 40 45 41 51 54 65 60
Operating Revenue		 39 32 37 44 40 45 41 51 54 65 60
Total Cost of Revenue		 12 11 13 15 15 14 14 16 16 19 18
Operating Cost of Revenue		 12 11 13 15 15 14 14 16 16 19 18
Total Operating Expenses		 47 43 33 38 39 49 45 49 42 49 49
Selling, General & Admin Expense		 40 37 29 33 34 44 40 44 37 44 44
Research & Development Expense		 7.13 5.82 4.27 5.49 4.80 5.14 5.06 5.20 4.56 5.43 5.24
Total Other Income / (Expense), net		 -7.57 -0.93 -6.93 -7.41 -3.03 -17 -2.85 -1.48 -6.70 -7.99 -6.58
Interest Expense		 3.68 4.34 4.38 5.19 5.31 5.95 5.85 5.96 6.20 7.24 7.09
Interest & Investment Income		 0.27 0.50 0.49 0.56 0.23 0.20 0.25 0.09 0.05 0.03 0.03
Other Income / (Expense), net		 -4.16 2.90 -3.04 -2.78 2.05 -12 2.75 4.38 -0.54 -0.78 0.48
Income Tax Expense		 0.67 -2.51 0.44 0.43 0.51 -1.41 0.91 1.00 0.42 -9.30 0.29
Basic Earnings per Share		 ($1.12) ($0.82) ($0.58) ($0.62) ($0.59) ($1.21) ($0.70) ($0.57) ($0.38) ($0.07) ($0.45)
Weighted Average Basic Shares Outstanding		 26.03M 25.60M 27.79M 27.91M 28.25M 28.16M 29.48M 28.91M 29.62M 29.62M 29.95M
Diluted Earnings per Share		 ($1.12) ($0.82) ($0.58) ($0.62) ($0.59) ($1.21) ($0.70) ($0.57) ($0.38) ($0.07) ($0.45)
Weighted Average Diluted Shares Outstanding		 26.03M 25.60M 27.79M 27.91M 28.25M 28.16M 29.48M 28.91M 29.62M 29.62M 29.95M
Weighted Average Basic & Diluted Shares Outstanding		 25.81M 27.21M 27.51M 27.94M 28.00M 28.85M 28.92M 28.97M 29.06M 29.32M 29.43M

Annual Cash Flow Statements for Establishment Labs

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 10 42 -15 47 -31 13 -26 50 -15
Net Cash From Operating Activities		 -32 -34 -30 -13 -28 -52 -89 -59 -51
Net Cash From Continuing Operating Activities		 -32 -34 -30 -13 -28 -52 -89 -59 -51
Net Income / (Loss) Continuing Operations		 -35 -21 -38 -38 -41 -75 -79 -85 -51
Consolidated Net Income / (Loss)		 -35 -21 -38 -38 -41 -75 -79 -85 -51
Depreciation Expense		 1.94 2.81 3.29 3.35 3.72 3.87 4.17 6.83 9.56
Amortization Expense		 7.05 3.32 2.43 2.05 2.48 8.59 14 7.11 4.36
Non-Cash Adjustments To Reconcile Net Income		 5.83 9.27 10 9.51 14 32 8.97 29 7.67
Changes in Operating Assets and Liabilities, net		 -12 -28 -7.93 11 -6.76 -22 -37 -17 -21
Net Cash From Investing Activities		 -0.85 -5.73 -7.77 -5.56 -7.16 -35 -25 -16 -7.03
Net Cash From Continuing Investing Activities		 -0.85 -5.73 -7.77 -5.56 -7.16 -35 -25 -16 -7.03
Purchase of Property, Plant & Equipment		 -0.90 -1.73 -6.29 -2.42 -5.28 -33 -23 -8.53 -6.05
Acquisitions		 -0.04 -4.00 -1.48 -3.14 -1.88 -2.02 -1.33 -7.08 -0.98
Net Cash From Financing Activities		 43 82 23 65 4.05 100 86 126 40
Net Cash From Continuing Financing Activities		 43 82 23 65 4.05 100 86 126 40
Repayment of Debt		 -16 -5.39 -0.24 -0.28 0.00 -72 0.00 0.00 -1.02
Issuance of Debt		 39 0.00 25 0.00 0.00 168 0.00 24 35
Issuance of Common Equity		 28 88 0.00 64 0.00 0.00 85 99 0.00
Other Financing Activities, net		 0.00 -0.70 0.54 1.09 4.05 3.87 1.69 1.94 6.95
Effect of Exchange Rate Changes		 0.21 -0.14 -0.02 0.27 -0.47 -0.36 0.51 -1.46 2.71
Cash Interest Paid		 2.86 5.38 5.95 6.96 6.93 5.36 5.69 9.81 21
Cash Income Taxes Paid		 0.15 0.14 0.65 0.32 0.65 2.13 2.17 1.74 0.42

Quarterly Cash Flow Statements for Establishment Labs

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -38 -12 33 -18 -15 51 -21 -15 16 4.95 -7.47
Net Cash From Operating Activities		 -32 -8.15 -11 -14 -12 -21 -21 -19 -11 -0.16 -4.31
Net Cash From Continuing Operating Activities		 -32 -8.15 -11 -14 -12 -21 -21 -19 -11 -0.16 -4.31
Net Income / (Loss) Continuing Operations		 -29 -21 -16 -17 -17 -35 -21 -17 -11 -2.62 -13
Consolidated Net Income / (Loss)		 -29 -21 -16 -17 -17 -35 -21 -17 -11 -2.62 -13
Depreciation Expense		 1.06 1.22 1.27 1.42 1.99 2.15 2.34 2.36 2.39 2.49 2.48
Amortization Expense		 3.53 3.59 3.59 1.71 0.83 0.99 0.99 1.03 1.16 1.17 1.28
Non-Cash Adjustments To Reconcile Net Income		 6.50 0.47 5.76 6.16 2.36 15 1.62 -1.79 3.97 3.87 3.99
Changes in Operating Assets and Liabilities, net		 -13 7.11 -5.57 -6.26 -0.96 -4.25 -4.96 -3.76 -7.62 -5.07 1.32
Net Cash From Investing Activities		 -6.60 -4.62 -6.63 -4.40 -2.77 -1.82 -1.34 -2.07 -1.96 -1.66 -1.96
Net Cash From Continuing Investing Activities		 -6.60 -4.62 -6.63 -4.40 -2.77 -1.82 -1.34 -2.07 -1.96 -1.66 -1.96
Purchase of Property, Plant & Equipment		 -6.36 -3.66 -4.75 -1.53 -1.63 -0.62 -0.75 -1.62 -1.85 -1.82 -1.85
Acquisitions		 -0.24 -0.96 -1.88 -2.87 -1.13 -1.20 -0.58 -0.45 -0.11 0.16 -0.11
Net Cash From Financing Activities		 0.49 0.07 51 0.39 -0.03 74 -0.20 5.13 29 6.05 -0.86
Net Cash From Continuing Financing Activities		 0.49 0.07 51 0.39 -0.03 74 -0.20 5.13 29 6.05 -0.86
Repayment of Debt		 - - - - - - 0.00 - - - -1.17
Other Financing Activities, net		 0.49 0.07 1.31 0.39 -0.03 0.28 -0.20 0.13 -0.05 7.07 0.31
Effect of Exchange Rate Changes		 -0.37 0.55 -0.32 -0.21 0.35 -1.27 1.10 1.16 -0.26 0.72 -0.34
Cash Interest Paid		 1.42 1.49 1.47 0.03 3.63 4.69 5.14 5.08 5.14 5.17 5.86
Cash Income Taxes Paid		 0.81 0.36 0.68 0.07 0.07 0.92 0.08 0.06 0.15 0.13 1.04

Annual Balance Sheets for Establishment Labs

This table presents Establishment Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 57 117 117 156 140 211 269 347 357
Total Current Assets		 39 99 96 132 113 150 175 243 250
Cash & Equivalents		 11 53 38 85 53 66 40 90 76
Accounts Receivable		 13 18 23 19 24 35 47 65 77
Inventories, net		 13 25 29 23 28 37 79 79 86
Prepaid Expenses		 2.24 4.30 6.76 5.44 7.01 12 8.48 8.92 11
Plant, Property, & Equipment, net		 14 13 16 16 19 51 77 78 76
Total Noncurrent Assets		 4.21 4.23 4.27 7.89 7.60 10 17 26 32
Goodwill		 0.47 0.47 0.47 0.47 0.47 0.47 0.47 1.21 1.21
Intangible Assets		 3.40 3.45 3.44 4.15 4.37 4.61 7.99 12 9.94
Other Noncurrent Operating Assets		 0.35 0.32 0.37 3.27 2.76 4.99 8.08 13 20
Total Liabilities & Shareholders' Equity		 57 117 117 156 140 211 269 347 357
Total Liabilities		 62 47 77 81 89 219 250 294 334
Total Current Liabilities		 57 16 23 26 32 39 57 68 82
Accounts Payable		 9.13 6.24 10 9.72 14 20 42 45 43
Accrued Expenses		 2.33 6.13 11 15 16 17 14 17 19
Other Current Liabilities		 46 4.08 2.20 1.65 1.18 1.69 1.84 6.98 20
Total Noncurrent Liabilities		 4.67 31 54 56 57 180 193 225 251
Long-Term Debt		 0.00 22 48 50 52 175 189 220 248
Other Noncurrent Operating Liabilities		 4.67 8.32 5.53 5.70 5.00 4.83 4.36 5.88 3.96
Commitments & Contingencies		 - - 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -5.01 69 40 75 51 -8.19 18 53 24
Total Preferred & Common Equity		 -5.01 69 40 75 51 -8.19 18 53 24
Total Common Equity		 -5.01 69 40 75 51 -8.19 18 53 24
Common Stock		 69 161 169 240 256 274 379 497 521
Retained Earnings		 -68 -89 -127 -165 -206 -282 -360 -445 -496
Treasury Stock		 -6.47 -2.85 -2.85 -2.85 -2.85 - -2.85 - -2.85
Accumulated Other Comprehensive Income / (Loss)		 0.08 0.45 0.69 2.87 3.66 2.72 1.96 3.29 1.16

Quarterly Balance Sheets for Establishment Labs

This table presents Establishment Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 188 209 285 271 302 285 283 333 330 339 351
Total Current Assets		 138 142 209 187 204 186 183 232 229 240 246
Cash & Equivalents		 65 43 90 52 73 55 40 69 55 71 68
Accounts Receivable		 31 41 51 55 51 60 67 63 70 71 77
Inventories, net		 32 46 56 68 72 64 67 90 95 88 87
Prepaid Expenses		 10 12 11 12 7.39 7.34 8.88 8.86 9.75 9.37 14
Plant, Property, & Equipment, net		 39 57 66 73 79 80 79 76 76 76 75
Total Noncurrent Assets		 10 10 10 11 19 19 20 25 24 23 31
Goodwill		 0.47 0.47 0.47 0.47 0.47 0.47 0.47 1.21 1.21 1.21 1.21
Intangible Assets		 4.63 4.37 4.23 5.71 9.52 10 9.78 12 11 10 9.30
Other Noncurrent Operating Assets		 5.18 5.44 5.38 5.00 8.92 8.90 10 13 12 11 20
Total Liabilities & Shareholders' Equity		 188 209 285 271 302 285 283 333 330 339 351
Total Liabilities		 186 225 230 240 245 240 250 295 307 323 336
Total Current Liabilities		 32 41 43 50 48 42 50 69 81 72 83
Accounts Payable		 15 20 24 29 31 28 34 45 56 40 42
Accrued Expenses		 17 20 17 19 15 12 14 21 17 18 22
Other Current Liabilities		 0.79 1.58 1.48 1.99 1.74 1.66 2.28 3.25 7.57 14 19
Total Noncurrent Liabilities		 154 184 187 190 197 198 199 226 226 251 253
Long-Term Debt		 148 179 182 185 192 194 194 220 221 246 249
Other Noncurrent Operating Liabilities		 5.57 5.24 5.18 4.42 4.73 4.45 5.12 5.44 5.03 4.09 4.51
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1.52 -16 55 30 57 45 33 39 23 16 15
Total Preferred & Common Equity		 1.52 -16 55 30 57 45 33 39 23 16 15
Total Common Equity		 1.52 -16 55 30 57 45 33 39 23 16 15
Common Stock		 270 278 366 371 434 438 442 504 508 511 524
Retained Earnings		 -268 -294 -310 -340 -376 -393 -410 -465 -482 -493 -509
Treasury Stock		 -2.85 - -2.85 -2.85 -2.85 -2.85 -2.85 -2.85 -2.85 -2.85 -2.85
Accumulated Other Comprehensive Income / (Loss)		 2.60 2.31 1.81 1.95 2.08 3.12 3.23 3.16 -0.37 1.43 2.37

Annual Metrics And Ratios for Establishment Labs

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - 29,057,868.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 29,057,868.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - -1.76
Growth Metrics		 - - - - - - - - -
Profitability Metrics		 - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -14 -17 -22 -20 -18 -28 -46 -35 -27
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -16.60% -21.98% -12.83% -10.07%
Earnings before Interest and Taxes (EBIT)		 -24 -12 -29 -29 -31 -42 -64 -65 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -15 -5.96 -23 -23 -24 -30 -46 -51 -19
Valuation Ratios		 - - - - - - - - -
Leverage & Solvency		 - - - - - - - - -
Liquidity Ratios		 - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -72 -33 -9.71 -27 -79 -112 -50 -40
Efficiency Ratios		 - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 -16 39 50 40 49 101 167 182 195
Increase / (Decrease) in Invested Capital		 0.00 55 11 -9.83 8.96 52 66 15 13
Book Value per Share		 ($0.49) $3.38 $1.92 $3.20 $2.11 ($0.34) $0.71 $1.90 $0.81
Tangible Book Value per Share		 ($0.87) $3.19 $1.73 $3.00 $1.91 ($0.54) $0.39 $1.44 $0.43
Total Capital		 -5.01 92 88 125 103 167 207 273 271
Total Debt		 0.00 22 48 50 52 175 189 220 248
Total Long-Term Debt		 0.00 22 48 50 52 175 189 220 248
Net Debt		 -11 -30 10 -35 -1.51 109 149 129 172
Capital Expenditures (CapEx)		 0.90 1.73 6.29 2.42 5.28 33 23 8.53 6.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -29 30 35 22 28 45 78 84 92
Debt-free Net Working Capital (DFNWC)		 -18 83 73 106 81 111 118 175 168
Net Working Capital (NWC)		 -18 83 73 106 81 111 118 175 168
Net Nonoperating Expense (NNE)		 21 4.39 16 19 24 47 33 50 24
Net Nonoperating Obligations (NNO)		 -11 -30 10 -35 -1.51 109 149 129 172
Total Depreciation and Amortization (D&A)		 8.99 6.13 5.72 5.40 6.20 12 18 14 14
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($3.41) ($1.22) ($1.86) ($1.63) ($1.72) ($3.08) ($3.07) ($3.00) ($1.72)
Adjusted Weighted Average Basic Shares Outstanding		 10.23M 20.39M 23.33M 23.55M 23.97M 24.46M 25.60M 28.16M 29.62M
Adjusted Diluted Earnings per Share		 ($3.41) ($1.22) ($1.86) ($1.63) ($1.72) ($3.08) ($3.07) ($3.00) ($1.72)
Adjusted Weighted Average Diluted Shares Outstanding		 10.23M 20.39M 23.33M 23.55M 23.97M 24.46M 25.60M 28.16M 29.62M
Adjusted Basic & Diluted Earnings per Share		 ($3.41) ($1.22) ($1.86) ($1.63) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.23M 17.35M 20.54M 23.32M 24.12M 24.42M 27.21M 28.85M 29.32M
Normalized Net Operating Profit after Tax (NOPAT)		 -14 -17 -22 -20 -18 -28 -46 -35 -27
Debt Service Ratios		 - - - - - - - - -
Payout Ratios		 - - - - - - - - -

Quarterly Metrics And Ratios for Establishment Labs

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - 29,057,868.00 29,320,846.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 29,057,868.00 29,320,846.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -0.09 -0.46
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.68% -27.97% -20.11% -9.15% 4.47% 41.05% 11.33% 16.28% 33.70% - 44.71%
EBITDA Growth		 -99.58% -116.41% -123.92% -13.57% 59.83% -87.85% -54.96% 29.56% 87.64% - 79.11%
EBIT Growth		 -78.25% -81.80% -59.75% 2.00% 55.97% -57.13% -19.56% 19.79% 58.83% - 57.50%
NOPAT Growth		 -100.04% -68.05% -8.26% 31.86% 37.55% 15.58% -91.83% -50.97% 69.37% - 61.58%
Net Income Growth		 -57.31% -51.47% -35.67% -2.60% 43.01% -68.10% -27.82% 3.42% 33.19% - 35.38%
EPS Growth		 -47.37% -46.43% -20.83% 4.62% 47.32% -47.56% -20.69% 8.06% 35.59% - 35.71%
Operating Cash Flow Growth		 -43.36% 41.87% 45.90% 49.88% 60.46% -154.65% -85.84% -32.49% 9.72% - 79.20%
Free Cash Flow Firm Growth		 -116.33% -34.08% 10.53% 48.90% 66.70% 65.35% 59.27% 65.98% 70.30% - 60.25%
Invested Capital Growth		 93.95% 65.57% 47.00% 25.56% 13.51% 9.11% 7.72% 2.77% 3.49% - 2.93%
Revenue Q/Q Growth		 -20.71% -18.04% 17.77% 18.70% -8.82% 10.66% -7.05% 23.98% 4.84% - -7.34%
EBITDA Q/Q Growth		 -160.15% 30.11% 51.31% -28.28% 7.98% -226.81% 59.83% 41.69% 83.85% - -116.60%
EBIT Q/Q Growth		 -103.69% 23.75% 38.21% -2.12% 8.50% -172.14% 52.99% 31.49% 53.03% - -28.20%
NOPAT Q/Q Growth		 -53.42% -5.12% 60.05% -5.77% -40.61% -42.10% 9.23% 16.75% 71.47% - -65.67%
Net Income Q/Q Growth		 -74.82% 29.83% 21.13% -6.04% 2.90% -107.00% 40.02% 19.88% 32.83% - -411.74%
EPS Q/Q Growth		 -72.31% 26.79% 29.27% -6.90% 4.84% -105.08% 42.15% 18.57% 33.33% - -542.86%
Operating Cash Flow Q/Q Growth		 -11.58% 74.14% -36.87% -26.92% 11.96% -66.51% 0.12% 9.52% 40.01% - -2,560.49%
Free Cash Flow Firm Q/Q Growth		 -9.07% 13.11% 23.47% 29.55% 28.92% 9.60% 10.03% 41.15% 37.96% - 36.45%
Invested Capital Q/Q Growth		 11.56% 2.13% 5.40% 4.56% 0.85% -1.83% 4.05% -0.24% 1.55% - -0.11%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 67.66% 65.23% 65.60% 65.59% 63.93% 68.50% 67.21% 68.76% 70.09% - 70.70%
EBITDA Margin		 -53.50% -45.62% -18.86% -20.39% -20.57% -60.76% -26.26% -12.35% -1.90% - -3.79%
Operating Margin		 -54.64% -70.07% -23.77% -21.18% -32.66% -41.94% -40.96% -27.50% -7.48% - -10.87%
EBIT Margin		 -65.43% -60.88% -31.94% -27.48% -27.58% -67.82% -34.30% -18.96% -8.49% - -10.07%
Profit (Net Income) Margin		 -76.02% -65.09% -43.59% -38.94% -41.47% -77.57% -50.05% -32.35% -20.72% - -22.35%
Tax Burden Percent		 102.34% 89.13% 102.78% 102.55% 103.15% 96.08% 104.62% 106.44% 103.95% - 102.20%
Interest Burden Percent		 113.53% 119.96% 132.79% 138.19% 145.79% 119.05% 139.48% 160.31% 234.77% - 217.08%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 -54.72% -60.45% -17.52% -13.57% -20.04% -27.90% -26.68% -18.29% -5.29% - -9.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 -68.19% -64.38% -25.38% -22.78% -25.27% -43.34% -33.23% -22.69% -10.36% - -14.40%
Return on Net Nonoperating Assets (RNNOA)		 -460.15% -1,625.54% -158.16% -52.66% -114.41% -168.51% -94.10% -102.30% -69.42% - -89.54%
Return on Equity (ROE)		 -514.87% -1,685.99% -175.68% -66.23% -134.44% -196.41% -120.79% -120.59% -74.72% - -98.62%
Cash Return on Invested Capital (CROIC)		 -95.58% -83.35% -69.14% -48.62% -34.07% -28.74% -29.67% -26.30% -23.34% - -13.28%
Operating Return on Assets (OROA)		 -50.67% -41.92% -19.47% -14.58% -15.26% -36.59% -18.39% -10.94% -5.22% - -6.76%
Return on Assets (ROA)		 -58.87% -44.82% -26.57% -20.67% -22.95% -41.85% -26.83% -18.67% -12.73% - -14.99%
Return on Common Equity (ROCE)		 -514.87% -1,685.99% -175.68% -66.23% -134.44% -196.41% -120.79% -120.59% -74.72% - -98.62%
Return on Equity Simple (ROE_SIMPLE)		 -234.60% 0.00% -145.42% -184.81% -215.86% 0.00% -231.14% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 -15 -15 -6.18 -6.54 -9.20 -13 -12 -9.87 -2.82 -2.75 -4.56
NOPAT Margin		 -38.24% -49.05% -16.64% -14.83% -22.86% -29.36% -28.67% -19.25% -5.24% - -7.61%
Net Nonoperating Expense Percent (NNEP)		 13.47% 3.93% 7.86% 9.22% 5.23% 15.44% 6.55% 4.40% 5.07% - 5.32%
Return On Investment Capital (ROIC_SIMPLE)		 - -7.47% - - - -4.79% -4.58% -4.05% -1.07% -1.01% -1.73%
Cost of Revenue to Revenue		 32.34% 34.78% 34.40% 34.41% 36.07% 31.50% 32.79% 31.24% 29.91% - 29.30%
SG&A Expenses to Revenue		 103.78% 116.86% 77.87% 74.33% 84.66% 98.89% 95.94% 86.11% 69.10% - 72.82%
R&D to Revenue		 18.51% 18.44% 11.50% 12.44% 11.93% 11.56% 12.22% 10.14% 8.47% - 8.75%
Operating Expenses to Revenue		 122.29% 135.30% 89.36% 86.77% 96.59% 110.44% 108.16% 96.26% 77.57% - 81.58%
Earnings before Interest and Taxes (EBIT)		 -25 -19 -12 -12 -11 -30 -14 -9.72 -4.57 -4.71 -6.03
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -21 -14 -7.01 -8.99 -8.28 -27 -11 -6.34 -1.02 -1.05 -2.27
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 41.49 36.32 24.33 27.77 36.96 24.29 30.53 54.26 72.57 - 112.62
Price to Tangible Book Value (P/TBV)		 52.01 67.20 29.51 36.23 53.83 32.08 45.67 119.12 249.74 - 389.80
Price to Revenue (P/Rev)		 7.13 4.05 8.89 8.26 7.90 7.77 6.91 6.96 6.22 - 7.25
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 8.54 4.89 8.54 7.54 7.34 7.78 7.00 7.41 7.09 - 9.45
Enterprise Value to Revenue (EV/Rev)		 7.88 4.95 9.65 9.18 8.91 8.55 7.80 7.90 7.14 - 8.04
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 6.08 10.26 3.38 4.30 5.94 4.14 5.72 9.71 15.06 - 16.82
Long-Term Debt to Equity		 6.08 10.26 3.38 4.30 5.94 4.14 5.72 9.71 15.06 - 16.82
Financial Leverage		 6.75 25.25 6.23 2.31 4.53 3.89 2.83 4.51 6.70 - 6.22
Leverage Ratio		 14.32 46.98 12.49 5.71 8.75 8.61 6.65 9.07 12.67 - 12.83
Compound Leverage Factor		 16.25 56.36 16.59 7.89 12.76 10.25 9.28 14.54 29.74 - 27.86
Debt to Total Capital		 85.87% 91.12% 77.15% 81.14% 85.59% 80.53% 85.11% 90.67% 93.77% - 94.39%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 85.87% 91.12% 77.15% 81.14% 85.59% 80.53% 85.11% 90.67% 93.77% - 94.39%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 14.13% 8.88% 22.85% 18.86% 14.41% 19.47% 14.89% 9.33% 6.23% - 5.61%
Debt to EBITDA		 -4.75 -4.10 -3.85 -3.80 -5.02 -4.28 -3.99 -4.21 -5.44 - -23.29
Net Debt to EBITDA		 -3.41 -3.23 -2.39 -2.73 -4.00 -2.52 -2.74 -3.17 -3.88 - -16.91
Long-Term Debt to EBITDA		 -4.75 -4.10 -3.85 -3.80 -5.02 -4.28 -3.99 -4.21 -5.44 - -23.29
Debt to NOPAT		 -4.72 -4.15 -4.18 -4.51 -5.20 -6.28 -5.42 -5.03 -6.55 - -12.43
Net Debt to NOPAT		 -3.39 -3.27 -2.59 -3.24 -4.14 -3.69 -3.72 -3.78 -4.67 - -9.02
Long-Term Debt to NOPAT		 -4.72 -4.15 -4.18 -4.51 -5.20 -6.28 -5.42 -5.03 -6.55 - -12.43
Altman Z-Score		 2.36 0.63 2.65 2.19 1.85 1.64 1.40 1.35 1.28 - 2.09
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.71 3.06 4.24 4.44 3.62 3.56 3.36 2.84 3.33 - 2.96
Quick Ratio		 2.12 1.52 2.58 2.74 2.12 2.28 1.92 1.54 1.97 - 1.75
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -94 -82 -62 -44 -31 -28 -25 -15 -9.29 -16 -10
Operating Cash Flow to CapEx		 -495.77% -222.50% -234.93% -925.70% -763.07% -3,352.02% -2,752.32% -1,154.74% -608.77% - -232.60%
Free Cash Flow to Firm to Interest Expense		 -25.55 -18.82 -14.27 -8.49 -5.89 -4.76 -4.35 -2.52 -1.50 - -1.43
Operating Cash Flow to Interest Expense		 -8.57 -1.88 -2.55 -2.73 -2.35 -3.49 -3.54 -3.15 -1.81 - -0.61
Operating Cash Flow Less CapEx to Interest Expense		 -10.29 -2.72 -3.63 -3.02 -2.65 -3.59 -3.67 -3.42 -2.11 - -0.87
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.77 0.69 0.61 0.53 0.55 0.54 0.54 0.58 0.61 - 0.67
Accounts Receivable Turnover		 4.13 4.01 3.39 2.72 2.51 2.97 2.98 2.73 2.75 - 3.27
Inventory Turnover		 1.26 1.00 0.92 0.85 0.79 0.71 0.70 0.73 0.77 - 0.78
Fixed Asset Turnover		 3.17 2.57 2.29 2.08 2.01 2.14 2.19 2.28 2.45 - 3.04
Accounts Payable Turnover		 2.87 1.89 2.12 1.95 1.69 1.31 1.50 1.38 1.61 - 1.58
Days Sales Outstanding (DSO)		 88.41 90.99 107.64 134.30 145.39 123.03 122.29 133.80 132.54 - 111.54
Days Inventory Outstanding (DIO)		 288.91 364.08 397.13 428.17 461.11 511.12 519.04 498.86 474.64 - 470.14
Days Payable Outstanding (DPO)		 127.21 193.43 171.81 187.41 216.21 279.03 242.96 264.43 226.55 - 230.98
Cash Conversion Cycle (CCC)		 250.11 261.64 332.95 375.06 390.30 355.12 398.38 368.23 380.63 - 350.70
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 164 167 176 184 186 182 190 189 192 195 195
Invested Capital Turnover		 1.43 1.23 1.05 0.92 0.88 0.95 0.93 0.95 1.01 - 1.19
Increase / (Decrease) in Invested Capital		 79 66 56 37 22 15 14 5.11 6.48 13 5.56
Enterprise Value (EV)		 1,398 817 1,504 1,389 1,364 1,419 1,328 1,402 1,363 - 1,845
Market Capitalization		 1,265 668 1,385 1,250 1,209 1,290 1,177 1,235 1,188 - 1,665
Book Value per Share		 $1.18 $0.71 $2.09 $1.64 $1.17 $1.90 $1.34 $0.79 $0.56 $0.81 $0.50
Tangible Book Value per Share		 $0.94 $0.39 $1.73 $1.25 $0.80 $1.44 $0.89 $0.36 $0.16 $0.43 $0.15
Total Capital		 216 207 249 239 227 273 259 244 263 271 263
Total Debt		 185 189 192 194 194 220 220 221 246 248 249
Total Long-Term Debt		 185 189 192 194 194 220 220 221 246 248 249
Net Debt		 133 149 119 139 155 129 151 166 176 172 180
Capital Expenditures (CapEx)		 6.36 3.66 4.75 1.53 1.63 0.62 0.75 1.62 1.85 1.82 1.85
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 84 78 83 90 93 84 93 94 97 92 95
Debt-free Net Working Capital (DFNWC)		 136 118 156 144 132 175 163 148 168 168 163
Net Working Capital (NWC)		 136 118 156 144 132 175 163 148 168 168 163
Net Nonoperating Expense (NNE)		 15 5.06 10 11 7.48 21 8.85 6.72 8.33 -0.14 8.82
Net Nonoperating Obligations (NNO)		 133 149 119 139 153 129 151 166 176 172 180
Total Depreciation and Amortization (D&A)		 4.60 4.82 4.86 3.13 2.82 3.14 3.33 3.39 3.54 3.66 3.76
Debt-free, Cash-free Net Working Capital to Revenue		 47.48% 47.06% 53.08% 59.23% 60.60% 50.84% 54.91% 52.86% 50.79% - 41.19%
Debt-free Net Working Capital to Revenue		 76.90% 71.30% 99.93% 95.30% 86.53% 105.26% 95.55% 83.66% 87.77% - 70.86%
Net Working Capital to Revenue		 76.90% 71.30% 99.93% 95.30% 86.53% 105.26% 95.55% 83.66% 87.77% - 70.86%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.12) ($0.82) ($0.58) ($0.62) ($0.59) ($1.21) ($0.70) ($0.57) ($0.38) ($0.07) ($0.45)
Adjusted Weighted Average Basic Shares Outstanding		 26.03M 25.60M 27.79M 27.91M 28.25M 28.16M 29.48M 28.91M 29.62M 29.62M 29.95M
Adjusted Diluted Earnings per Share		 ($1.12) ($0.82) ($0.58) ($0.62) ($0.59) ($1.21) ($0.70) ($0.57) ($0.38) ($0.07) ($0.45)
Adjusted Weighted Average Diluted Shares Outstanding		 26.03M 25.60M 27.79M 27.91M 28.25M 28.16M 29.48M 28.91M 29.62M 29.62M 29.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.81M 27.21M 27.51M 27.94M 28.00M 28.85M 28.92M 28.97M 29.06M 29.32M 29.43M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -15 -6.18 -6.54 -9.20 -13 -12 -9.87 -2.82 -2.75 -4.56
Normalized NOPAT Margin		 -38.24% -49.05% -16.64% -14.83% -22.86% -29.36% -28.67% -19.25% -5.24% - -7.61%
Pre Tax Income Margin		 -74.28% -73.03% -42.41% -37.97% -40.20% -80.74% -47.84% -30.39% -19.94% - -21.87%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -6.85 -4.43 -2.71 -2.34 -2.09 -5.07 -2.42 -1.63 -0.74 - -0.85
NOPAT to Interest Expense		 -4.00 -3.57 -1.41 -1.26 -1.73 -2.20 -2.03 -1.66 -0.45 - -0.64
EBIT Less CapEx to Interest Expense		 -8.58 -5.27 -3.79 -2.63 -2.40 -5.18 -2.55 -1.91 -1.03 - -1.11
NOPAT Less CapEx to Interest Expense		 -5.73 -4.41 -2.50 -1.56 -2.04 -2.30 -2.16 -1.93 -0.75 - -0.90
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Establishment Labs (NASDAQ: ESTA) has shown a rebound in top-line momentum in late-2025 after a softer 2024, but profitability remains a challenge due to elevated operating spending and significant leverage. Over the last four quarters, revenue has trended higher, gross margins have remained broadly stable around the 70% mark, and cash flow from operations has improved notably in Q4 2025, even as the company continues to rely on financing activity to fund ongoing operations. The balance sheet shows a high debt load relative to assets, but liquidity remains solid thanks to a substantial cash balance and favorable current assets vs. current liabilities.

  • Q4 2025 revenue rose to 64.6 million, up from 53.8 million in Q3 2025 and well above earlier 2025 quarters, signaling renewed top-line momentum.
  • Gross margin held near 70% in Q4 2025 (gross profit about 45.5 million on 64.6 million in revenue), indicating stable pricing and cost-of-revenue discipline.
  • Net income narrowed in Q4 2025 to about -2.6 million, a meaningful improvement versus the larger losses seen in prior quarters (e.g., -11.1 million in Q3 2025), suggesting improving profitability trajectory.
  • Q4 2025 operating cash burn narrowed to near breakeven (-0.16 million) from larger cash losses in earlier quarters, marking a notable improvement in cash flow from operations.
  • Financing activities remained a key liquidity source across recent quarters, with sizable inflows from equity/debt financing (e.g., Q3 2025 and Q1 2025), contributing to liquidity but also indicating ongoing reliance on external funding.
  • Balance-sheet liquidity remains solid, with cash and equivalents around 70 million in several 2025 quarters and current assets substantially higher than current liabilities, preserving a multi-quarter liquidity cushion.
  • Current ratio has typically run above 3x in recent periods, reflecting a strong short-term liquidity position despite a high debt load.
  • Net income has remained negative across the period, highlighting persistent profitability challenges despite revenue growth.
  • Long-term debt has been substantial (roughly 220–246 million in recent quarters), contributing to high leverage and interest expense headwinds.
  • Operating expenses (selling, general & administrative plus research & development) remain elevated relative to gross profit in Q4 2025, driving a negative operating margin and ongoing cash burn without continued financing support.
06/01/26 04:04 AM ETAI Generated. May Contain Errors.

Establishment Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Establishment Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Establishment Labs' net income appears to be on an upward trend, with a most recent value of -$51.06 million in 2025, rising from -$34.90 million in 2017. The previous period was -$84.60 million in 2024. See where experts think Establishment Labs is headed by visiting Establishment Labs' forecast page.

Establishment Labs' total operating income in 2025 was -$39.01 million, based on the following breakdown:
  • Total Gross Profit: $146.31 million
  • Total Operating Expenses: $185.32 million

Over the last 8 years, Establishment Labs' total revenue changed from $34.68 million in 2017 to $211.08 million in 2025, a change of 508.6%.

Establishment Labs' total liabilities were at $333.62 million at the end of 2025, a 13.6% increase from 2024, and a 437.2% increase since 2017.

In the past 8 years, Establishment Labs' cash and equivalents has ranged from $10.86 million in 2017 to $90.35 million in 2024, and is currently $75.57 million as of their latest financial filing in 2025.

Over the last 8 years, Establishment Labs' book value per share changed from -0.49 in 2017 to 0.81 in 2025, a change of -265.4%.


Related Companies

Financial statements for NASDAQ:ESTA last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel